Work

Supplementary Figure S8 from Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non–Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling

Year: 2023

Type: supplementary-materials

Abstract: A-B. PFS according to CD56+/CD3- cell counts in stroma (A) and CD56+/CD3+ cell counts in stroma (B); C-D. OS according to CD56+/CD3- cell counts in stroma (C) and CD56+/CD3+ cell counts in stroma (D)

DOI: 10.1158/1078-0432.22476975.v1

Authors: Jon Zugazagoitia, Swati Gupta, Yuting Liu, Kit Fuhrman, Scott Gettinger, Roy S. Herbst, Kurt A. Schalper, David L. Rimm

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361937222

Cites:

Cited by:

Related to: 10